HCCC-9810胆管癌细胞,HCCC-9810 cells
1)HCCC-9810 cellsHCCC-9810胆管癌细胞
2)Cholangiocarcinoma胆管细胞癌
1.Ultrasographic Diagnosis of Intrahepatic Cholangiocarcinoma;肝内胆管细胞癌的超声诊断
2.Analysis of Percutaneous Microwave Coagulation Therapy with Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma in 27 Cases;微波凝固联合肝动脉化疗栓塞治疗肝内胆管细胞癌27例分析
3.The Diagnosis of Peripheral Cholangiocarcinoma in Low Field MRI;肝内周围性胆管细胞癌低场MRI诊断
英文短句/例句

1.Evaluation Study of Peripheral Cholangiocarcinoma and Hepatocellular Carcinoma Examined by MR;胆管细胞癌与肝细胞癌的MR诊断价值
2.Primary Intrahepatic Peripheral Cholangiocarcinoma:CT Findings原发性肝内周围型胆管细胞癌CT表现
3.Significance of expression of Twist and E-cadherin in cholangiocarcinomaTwist、E-cadherin在胆管细胞癌中的表达及意义
4.CT findings of intrahepatic peripheral cholangiocarcinoma18例肝内胆管细胞癌的CT表现分析
5.Clinical significance of CT classification of intrahepatic cholangiocarcinoma肝内胆管细胞癌CT分型及临床意义
6.In Vivo Proton Magnetic Resonance Spectroscopy of Hepatocellular Carcinoma and Cholangiocarcinoma肝细胞癌和胆管细胞癌活体氢质子磁共振波谱分析
7.The Biomolecular Mechanism of the Enhancement Difference on Spiral CT in Hepatocellular Carcinoma and Intrahepatic Cholangiocellular Carcinoma肝细胞癌和胆管细胞癌螺旋CT增强差异的分子生物学基础
8.Clinical and MR differential diagnosis of peripheral cholangiocarcinoma and hepatocellular carcinoma周围型胆管细胞癌与肝细胞癌的临床及MR鉴别诊断
9.“Therapy of Ablation andRadioactive Seed Implantation for Klatskin Tumor”汇管区胆管细胞癌的消融及粒子植入治疗
10.Clinical Research of Prognostic Factors of Affecting Intrahepatic Cholangiocarcinoma;影响肝内胆管细胞癌预后因素的临床研究
11.Expression of Caspase-3 and Survivinin in Cholangioma and Its Implication;Survivin与Caspase-3在胆管细胞癌中的表达及相关性研究
12.Proliferative Effects for a Cholangiocarcinoma Cell Line of Bile From Patients with Biliary Calculi and with Bile Tract Neoplasm;成石性胆汁及胆管癌性胆汁对人肝门部胆管癌细胞增殖的影响
13.A liver cancer may have both hepatocellular as well as cholangiolar differentiation.肝癌可具有肝细胞分化和胆管分化。
14.The Role of UPR in Human Cholangiocarcinoma QBC939 Cells;UPR在人胆管癌细胞株QBC939中的作用
15.Effects of Cyclooxygenase-2 Inhibitor Celecoxib on the Expression of VEGF in Human Cholangiocarcinoma QBC939 Cell Lines;Celecoxib对胆管癌细胞株QBC939 VEGF表达的影响
16.Expression and Significance of Bcl-2 in Cholangiocarcinoma Tissue and Research of Bcl-2 ASODN Effect on Cholangiocarcinoma Cell Line QBC939;胆管癌中Bcl-2表达意义及Bcl-2 ASODN对胆管癌细胞影响的实验研究
17.Expression and Significance of Livin in Human Cholangiocarcinoma Tissues and Cell LineLivin基因在人胆管癌组织及胆管癌细胞系中的表达和意义
18.Contrast and Analysis of the Immunohistochemical Difference between the Intrahepatic Cholangiocarcinoma and Hepatic Cell Arcinoma;肝内胆管癌与肝细胞癌免疫差异对比分析
相关短句/例句

Cholangiocarcinoma胆管细胞癌
1.Ultrasographic Diagnosis of Intrahepatic Cholangiocarcinoma;肝内胆管细胞癌的超声诊断
2.Analysis of Percutaneous Microwave Coagulation Therapy with Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma in 27 Cases;微波凝固联合肝动脉化疗栓塞治疗肝内胆管细胞癌27例分析
3.The Diagnosis of Peripheral Cholangiocarcinoma in Low Field MRI;肝内周围性胆管细胞癌低场MRI诊断
3)Cholangiocarcinoma胆管癌细胞
1.Inhibitory Effects of PTEN Gene Mediated Combine with L-OHP on Human Cholangiocarcinoma Cell Line;PTEN基因联合奥沙利铂对胆管癌细胞生长抑制的研究
2.ConclusionThe two drugs can synergistically demethylate and re-express P16 and RASSF1A genes in QBC939 cells,so they are promising drugs for cholangiocarcinoma.目的探讨利用甲基化酶抑制剂(肼屈嗪)和组蛋白脱乙酰化酶抑制剂(丙戊酸)干预胆管癌细胞后,对P16和RASSF1A基因表达的影响。
4)intrahepatic cholangiocarcinoma肝内胆管细胞癌
1.Clinical features of intrahepatic cholangiocarcinoma in the elderly people;老年人肝内胆管细胞癌临床特征
2.CT Diagnosis and Differential Diagnosis of Intrahepatic Cholangiocarcinoma;肝内胆管细胞癌CT诊断及鉴别诊断
3.Preventive effect of mitomycin C injection via great omentum vein during resection of intrahepatic cholangiocarcinoma against carcinoma recurrence;肝内胆管细胞癌肝切除治疗术中经大网膜静脉注射丝裂霉素预防复发疗效分析
5)intrahepatic cholangiocarcinoma胆管细胞型肝癌
1.Purpose: To evaluate the CT imaging findings of intrahepatic cholangiocarcinoma.目的 :探讨胆管细胞型肝癌的CT表现。
6)cholangicarcinoma cell胆管上皮癌细胞
1.Effect of prostaglandin E_2 on the proliferation of human cholangicarcinoma cell;前列腺素E_2对胆管上皮癌细胞增殖的影响
延伸阅读

[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]分子式:C16H16ClN3O3S分子量:365.5CAS号:26807-65-8性质:暂无制备方法:暂无用途:用于轻、中度原发性高血压。